Research programme: HIV-1 nucleocapsid protein inhibitors - ImQuest
Alternative Names: HIV-1 NCp7 protein inhibitors - ImQuest Biosciences; Virus-inactivating NCp7-targeted thioesters - ImQuest BiosciencesLatest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator ImQuest BioSciences
- Class Small molecules
- Mechanism of Action HIV zinc finger inhibitors; Viral protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in HIV-1-infections in USA (Topical)
- 06 Aug 2008 Preclinical development is ongoing in USA
- 01 Jun 2004 Preclinical trials in HIV-1 infections in USA (Topical)